Portfolio

Predemtec

Predemtec focuses on the research, development and manufacture of innovative diagnostic tests for use in the detection of dementia-related risk factors. The first product, the Predemtec DX test, is a serum-based immunoassay and uses analysis algorithms for the early detection and risk diagnosis of senile dementia (Alzheimer’s type, AD).

Management

Pressemeldungen

Predemtec GmbH receives seed financing from High-Tech Gruenderfonds for developing a blood test to diagnose Alzheimer`s Disease

Predemtec GmbH in Hennigsdorf develops a blood test for a reliable diagnosis of Alzheimer’s disease. In July 2014 the start-up received a seed financing from High-Tech Gruenderfonds (HTGF). The seed investment will be used to finalize the first test into a marketable product and to expand the scope of the test…
Read

Info & Contact

Address

St. Gallerstrasse 99
9200 Gossau SG
Schweiz

In portfolio

27. May 2014

Sector